ATOX BIO
Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.It focuses on novel modulators of the immune response that target key multiple and interrelated pathways of both the adaptive and innate immune response that play critical roles in infectious and inflammatory diseases as well as ischemia/reperfusion injuries. The company was founded in 2003 and headquartered in HaMerkaz, Israel.
ATOX BIO
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2003-01-01
Address:
Ness Ziona, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.atoxbio.com
Total Employee:
1+
Status:
Active
Contact:
97237582807
Total Funding:
58.35 M USD
Technology used in webpage:
Pound Sterling Japanese Yen Israeli Server Location
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Current Advisors List
Board_member
2014-07-01
Board_member
Board_member
Board_member
Current Employees Featured
Gila Arad Scientific consult, Founder @ Atox Bio
Scientific consult, Founder
Dan Teleman CEO @ Atox Bio
CEO
2010-01-01
Raymond Kaempfer Scientific Founder @ Atox Bio
Scientific Founder
WAYNE M DANKNER CMO @ Atox Bio
CMO
Founder
Investors List
SR One
SR One investment in Series F - Atox Bio
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series F - Atox Bio
The Becker Group
The Becker Group investment in Series F - Atox Bio
Asahi Kasei
Asahi Kasei investment in Series F - Atox Bio
Arix Bioscience
Arix Bioscience investment in Series F - Atox Bio
Integra Holdings
Integra Holdings investment in Series F - Atox Bio
OrbiMed
OrbiMed investment in Series F - Atox Bio
Adams Street Partners
Adams Street Partners investment in Series F - Atox Bio
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series E - Atox Bio
SR One
SR One investment in Series E - Atox Bio
Official Site Inspections
http://www.atoxbio.com
- Host name: server54-4.web-hosting.com
- IP address: 198.54.126.120
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Atox Bio"
Atox Bio - Crunchbase Company Profile & Funding
Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.It focuses on novel modulators of the immune response that target key …See details»
Atox Bio Company Profile | Management and Employees List
Atox Bio Profile and History. Atox Bio is a late stage clinical company that develops immunotherapies for critically ill patients. The ACCUTE study was funded in whole or in part …See details»
Atox Bio 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Atox Bio. Use the PitchBook Platform to explore the full profile.See details»
安腾瑞霖
Aton Biotech is a fast-growing CDMO company which is committed to enabling new biological drugs for clients with an integrated bio-pharmaceutical platform.See details»
Atox Bio Company Profile - Office Locations, Competitors ... - Craft
Atox Bio has 5 employees across 2 locations and $56.25 m in total funding,. See insights on Atox Bio including office locations, competitors, revenue, financials, executives, subsidiaries and …See details»
安腾瑞霖 - Aton Bio
是一家快速发展中的生物药 cdmo 公司，致力于以质量驱动的一体化生物制药开发生产平台，为客户新药研发生产赋能。 公司服务范围涵盖从细胞株构建至商业化生产的端到端 cdmo 服务，包括单克隆抗体、融合蛋白、双特异性抗体、 adc …See details»
Atox Bio - LinkedIn
Atox Bio | 49 followers on LinkedIn. Atox Bio is a late stage, critical care immunotherapy company focusing on acute, life threatening, conditions with significant unmet need. We are developing ...See details»
Atox Bio - Products, Competitors, Financials, Employees, …
Atox Bio operates as a late-stage, critical-care immunotherapy developing therapeutics for diseases mediated by a deregulated inflammatory response. Use the CB Insights Platform to …See details»
Atox Bio - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 5, 2025 Atox Bio - Developer of immunomodulators for treatment of rare disease. This company is not active anymore. Raised a total funding of $59.3M over 3 rounds from 10 …See details»
安腾瑞霖（上海）生物科技有限公司 - 爱企查
简介： 1、基本情况 安腾瑞霖（上海）生物科技有限公司是复星医药股份有限公司集团旗下的企业。该公司成立于2022年03月24日，位于上海市徐汇区宜山路1289号7幢6层605室，目前处于 …See details»
Atox Bio - Overview, News & Similar companies | ZoomInfo.com
Jul 9, 2020 View Atox Bio (www.atoxbio.com) location in North Carolina, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
ATOX BIO INC Company Profile | Durham, NC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ATOX BIO INC of Durham, NC. Get the latest business insights from Dun & Bradstreet.See details»
Atox Bio - JLM-BioCity
AtoxBioCeo: Dan TelemanYear Established: 2003AtoxBio is a late-stage biotechnology company that develops novel immunomodulators for critically ill patients.Reltecimod, AtoxBio’s lead …See details»
Atox Bio - Company Profile and News - Bloomberg Markets
Atox Bio is a biotechnology company. The Company provides research and development services. Atox offers discovery and development of therapeutics for the treatment of infectious …See details»
Atox Bio - Lundbeckfonden
Dec 16, 2020 Atox Bio’s initial focus is on patients with Necrotizing Soft Tissue Infections (NSTI, “flesh eating bacteria”), a rare, life threatening, infection for which no current therapy exists.See details»
Atox Bio Ltd. - BioCentury Company Profiles - BCIQ
Aug 27, 2021 Atox Bio Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
安腾瑞霖（上海）生物科技有限公司 - 企查查
Mar 24, 2022 2024-06-14 商标注册成功，安腾瑞霖分析检测服务平台 atones 2023-11-20 安腾瑞霖重磅推出：atonest分析检测服务平台，覆盖生物药全生命周期 2023-11-06 新增行政许可： …See details»
Atox Bio - Contacts, Employees, Board Members, Advisors & Alumni
Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.See details»
Atox Bio | Insights
Jul 5, 2021 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Atox Bio Closes $23 Million Investment - Fierce Biotech
Jul 24, 2014 NESS ZIONA, Israel--Atox Bio, developer of therapeutics for severe infections, today announced that it has raised up to $23 million in a Series E investment led by SR One …See details»